Literature DB >> 7362858

The complement system of the newborn infant.

J H Drew, C M Arroyave.   

Abstract

Whole complement activity (CH50), and levels of some components of the classical (C1q, C4, C3) and alternative (factor B and properdin) pathways were determined in 55 non-infected and 11 infected newborn infants. Normal newborn infants were lower than adults in all complement measurements; preterm infants being significantly lower than term infants. Complement was not effected by intrauterine growth retardation. Absence of C3 split products indicated that the deficiencies were developmental and not due to activation of the complement system. Complement levels were lower in infected infants and this was due to activation of the complement system as C3 split products were present in 54%. Because of the high incidence of split products in infected infants, incorporating a test to determine their presence may be of benefit in the diagnosis of the presence of infection in newborn infants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7362858     DOI: 10.1159/000241276

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  12 in total

1.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

2.  Comparison of three different methods for measuring classical pathway complement activity.

Authors:  T D Jaskowski; T B Martins; C M Litwin; H R Hill
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

3.  Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.

Authors:  Wolfgang Ernst; Nicole Zimara; Frank Hanses; Daniela N Männel; Birgit Seelbach-Göbel; Anja K Wege
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

Review 4.  Clinical utility of complement assessment.

Authors:  A E Ahmed; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

5.  Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

Authors:  C J Baker; M S Edwards; B J Webb; D L Kasper
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

6.  Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress.

Authors:  A Enskog; A Bengtsson; J P Bengtson; M Heideman; S Andreasson; L Larsson
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

7.  Complement fragment C3a in plasma of asphyxiated neonates.

Authors:  L Schrod; G Frauendienst-Egger; H B von Stockhausen; M Kirschfink
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 8.  Antifungal Immunological Defenses in Newborns.

Authors:  Christina Michalski; Bernard Kan; Pascal M Lavoie
Journal:  Front Immunol       Date:  2017-03-15       Impact factor: 7.561

9.  Altered Toll-Like Receptor-4 Response to Lipopolysaccharides in Infants Exposed to HIV-1 and Its Preventive Therapy.

Authors:  Anicet Christel Maloupazoa Siawaya; Ofilia Mvoundza Ndjindji; Eliane Kuissi Kamgaing; Amandine Mveang-Nzoghe; Chérone Nancy Mbani Mpega; Marielle Leboueny; Roselyne Kengue Boussougou; Armel Mintsa Ndong; Paulin N Essone; Joel Fleury Djoba Siawaya
Journal:  Front Immunol       Date:  2018-02-14       Impact factor: 7.561

10.  Comparative Analysis of Global Gene Expression and Complement Components Levels in Umbilical Cord Blood from Preterm and Term Neonates: Implications for Significant Downregulation of Immune Response Pathways related to Prematurity.

Authors:  Dorota Gródecka-Szwajkiewicz; Zofia Ulańczyk; Edyta Zagrodnik; Karolina Łuczkowska; Dorota Rogińska; Miłosz P Kawa; Iwona Stecewicz; Krzysztof Safranow; Przemysław Ustianowski; Sławomir Szymański; Bogusław Machaliński
Journal:  Int J Med Sci       Date:  2020-07-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.